[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bio-Techne Corp (TECH)

Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,127,734
  • Shares Outstanding, K 156,453
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 73,400 K
  • EBIT $ 117 M
  • EBITDA $ 227 M
  • 60-Month Beta 1.49
  • Price/Sales 6.86
  • Price/Cash Flow 21.89
  • Price/Book 4.16

Options Overview Details

View History
  • Implied Volatility 63.80% (+3.31%)
  • Historical Volatility 45.30%
  • IV Percentile 99%
  • IV Rank 98.25%
  • IV High 64.28% on 04/30/25
  • IV Low 36.75% on 09/16/25
  • Expected Move (DTE 15) 3.87 (7.31%)
  • Put/Call Vol Ratio 0.16
  • Today's Volume 80
  • Volume Avg (30-Day) 1,197
  • Put/Call OI Ratio 7.40
  • Today's Open Interest 13,877
  • Open Int (30-Day) 28,514
  • Expected Range 49.07 to 56.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.48
  • Number of Estimates 6
  • High Estimate $0.51
  • Low Estimate $0.40
  • Prior Year $0.50
  • Growth Rate Est. (year over year) -4.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
51.03 +3.21%
on 04/29/26
62.47 -15.69%
on 04/21/26
+0.63 (+1.21%)
since 03/30/26
3-Month
48.25 +9.16%
on 03/16/26
69.92 -24.67%
on 02/04/26
-11.42 (-17.82%)
since 01/30/26
52-Week
46.05 +14.38%
on 05/22/25
72.16 -27.01%
on 01/22/26
+2.32 (+4.61%)
since 04/30/25

Most Recent Stories

More News
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

TECH : 53.46 (+2.91%)
PCOR : 55.16 (-1.46%)
BMBL : 4.10 (-2.61%)
1 Profitable Stock to Target This Week and 2 We Brush Off

1 Profitable Stock to Target This Week and 2 We Brush Off

TECH : 53.46 (+2.91%)
MNST : 77.27 (+0.49%)
DOCU : 45.77 (-2.45%)
1 S&P 500 Stock to Own for Decades and 2 We Question

1 S&P 500 Stock to Own for Decades and 2 We Question

TECH : 53.46 (+2.91%)
IT : 146.79 (-2.29%)
AJG : 205.34 (-3.05%)
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know

Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know

TECH : 53.46 (+2.91%)
CORT : 46.65 (+0.13%)
SUPN : 48.94 (+0.80%)
PAHC : 52.72 (+0.42%)
RVTY : 85.27 (+3.66%)
What to Expect From Bio-Techne's Q3 2026 Earnings Report

Bio-Techne is set to announce its third-quarter earnings next month, and Wall Street expects the company’s EPS to decrease by a single digit.

TECH : 53.46 (+2.91%)
XLV : 145.64 (+1.96%)
$SPX : 7,139.27 (+0.05%)
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

MINNEAPOLIS , April 16, 2026 /CNW/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, today announced a streamlined...

TECH : 53.46 (+2.91%)
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity

MINNEAPOLIS , April 16, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and diagnostics, today announced a streamlined...

TECH : 53.46 (+2.91%)
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results

MINNEAPOLIS , April 14, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 6, 2026, at 8:00 a.m....

TECH : 53.46 (+2.91%)
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know

TECH : 53.46 (+2.91%)
BRKR : 35.58 (+3.76%)
WAT : 303.96 (+4.05%)
CNMD : 37.42 (+4.06%)
AVTR : 8.16 (+3.95%)
Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks

Q4 Research Tools & Consumables Earnings: Bio-Techne (NASDAQ:TECH) Earns Top Marks

TECH : 53.46 (+2.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

3rd Resistance Point 56.15
2nd Resistance Point 54.94
1st Resistance Point 53.45
Last Price 53.46
1st Support Level 50.74
2nd Support Level 49.53
3rd Support Level 48.04

See More

52-Week High 72.16
Fibonacci 61.8% 62.19
Fibonacci 50% 59.11
Fibonacci 38.2% 56.02
Last Price 53.46
52-Week Low 46.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.